The role of lifestyle characteristics on prostate cancer progression in two active surveillance cohorts.
Loading...
Embargo End Date
ICR Authors
Authors
Vandersluis, AD
Guy, DE
Klotz, LH
Fleshner, NE
Kiss, A
Parker, C
Venkateswaran, V
Guy, DE
Klotz, LH
Fleshner, NE
Kiss, A
Parker, C
Venkateswaran, V
Document Type
Journal Article
Date
2016-09-01
Date Accepted
2016-05-17
Abstract
BACKGROUND: Although much research has examined the relationship between lifestyle and prostate cancer (PCa) risk, few studies focus on the relationship between lifestyle and PCa progression. The present study examines this relationship among men initially diagnosed with low- to intermediate-risk PCa and managed with active surveillance (AS). METHODS: Men enrolled in two separate AS programs were recruited for this study. Data regarding clinical, demographic and lifestyle characteristics were collected. Results were then compared between men whose disease remained low- to intermediate-risk and men whose disease progressed. RESULTS: Demographic, clinical and physical characteristics were similar between comparative groups and cohorts, with the exception that age at the time of diagnosis and questionnaire was increased among men whose disease progressed. Lifestyle scores among men who remained low- to intermediate-risk were higher than those whose risk progressed; however, scores were only significant in one cohort on univariable analysis. On multivariable analysis, the only predictor of progression was age at diagnosis. Physical activity was consistently higher in both low risk groups, although this difference was insignificant. Consistent differences in other lifestyle variables were not observed. CONCLUSIONS: Age remains an important predictor of PCa progression. Improving lifestyle characteristics among men initially managed with AS might help to reduce the risk of progression. Given the limitations of this study, more rigorous investigation is required to confirm whether lifestyle characteristics influence the progression of low- to intermediate-risk PCa.
Citation
Prostate cancer and prostatic diseases, 2016, 19 (3), pp. 305 - 310
Source Title
Publisher
SPRINGERNATURE
ISSN
1365-7852
eISSN
1476-5608